Hiroaki Tanioka
   Department     Kawasaki Medical School, Department of Clinical Oncology,
   Position   Assistant Professor with Special Assignment
Language English
Title A randomized phase II study of weekly paclitaxel +/- trastuzumab in patients with HER2-positive advanced gastric or gastro-esophageal junction cancer refractory to trastuzumab combined with fluoropyrimidine and platinum: WJOG7112G (T-ACT).
Conference 2018 ASCO Annual Meeting
Conference Type International society and overseas society
Presentation Type Poster notice
Lecture Type General
Publisher and common publisherAkitaka Makiyama, Kosuke Sagara, Junji Kawada, Tomomi Kashiwada, Ayumu Hosokawa, Yoshiki Horie, Hironaga Satake, Yoshiyuki Yamamoto, Hiroaki Tanioka, Katsunori Shinozaki, Kazuhiro Nishikawa, Keita Uchino, Yasutaka Sukawa, Takeharu Yamanaka, Kentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, Ichinosuke Hyodo, Taito Esaki, Kei Muro
Date 2018/06/03
Venue
(city and name of the country)
Chicago, USA
Society abstract J Clin Oncol 36(Suppl),abstr 4011 2018